CHO Pharma, Inc. (6586) Stock Statistics & Valuation Metrics
Total Valuation
CHO Pharma, Inc. has a market cap or net worth of TWD 15.88B. The enterprise value is ―.
- Market Cap
- TWD 15.88B
- Enterprise Value
- ―
Share Statistics
CHO Pharma, Inc. has 214,010,500 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 214,010,500
- Owned by Insiders
- ―
- Owned by Institutions
- 0.02%
Financial Efficiency
CHO Pharma, Inc.’s return on equity (ROE) is -0.12 and return on invested capital (ROIC) is -13.15%.
- Return on Equity (ROE)
- -0.12
- Return on Assets (ROA)
- -0.11
- Return on Invested Capital (ROIC)
- -13.15%
- Return on Capital Employed (ROCE)
- -0.13
- Revenue Per Employee
- 40.89K
- Profits Per Employee
- -8.29M
- Employee Count
- 35
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of CHO Pharma, Inc. is -58.40. CHO Pharma, Inc.’s PEG ratio is 2.82.
- PE Ratio
- -58.40
- PS Ratio
- 9162.91
- PB Ratio
- 6.58
- Price to FCF
- -62.55
- Price to Operating Cash Flow
- -64.76
- PEG Ratio
- 2.82
Income Statement
In the last 12 months, CHO Pharma, Inc. had revenue of 1.43M and earned -290.01M in profits. Earnings per share was -1.36.
- Revenue
- 1.43M
- Gross Profit
- -25.54M
- Operating Income
- -325.84M
- Pretax Income
- -290.01M
- Net Income
- -290.01M
- EBITDA
- -299.15M
- Earnings Per Share (EPS)
- -1.36
Cash Flow
In the last 12 months, operating cash flow was -241.25M and capital expenditures -8.53M, giving a free cash flow of -249.78M billion.
- Operating Cash Flow
- -241.25M
- Free Cash Flow
- -249.78M
- Free Cash Flow per Share
- -1.17
Dividends & Yields
CHO Pharma, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -1.53%
- Earnings Yield
- -1.64%
Stock Price Statistics
- Beta
- 0.89
- 52-Week Price Change
- 133.70%
- 50-Day Moving Average
- ―
- 200-Day Moving Average
- ―
- Relative Strength Index (RSI)
- 23.14
- Average Volume (3m)
- 490.70K
Financial Position
CHO Pharma, Inc. as a current ratio of 19.47, with Debt / Equity ratio of 0.59%
- Current Ratio
- 19.47
- Quick Ratio
- 19.47
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.13
- Interest Coverage Ratio
- -802.56
Taxes
In the past 12 months, CHO Pharma, Inc. has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
CHO Pharma, Inc. EV to EBITDA ratio is -58.65, with an EV/FCF ratio of -65.25.
- EV to Sales
- 9558.64
- EV to EBITDA
- -58.65
- EV to Free Cash Flow
- -65.25
- EV to Operating Cash Flow
- -67.55
Balance Sheet
CHO Pharma, Inc. has TWD 1.96B in cash and marketable securities with TWD 7.33M in debt, giving a net cash position of TWD 1.95B billion.
- Cash & Marketable Securities
- TWD 1.96B
- Total Debt
- TWD 7.33M
- Net Cash
- TWD 1.95B
- Net Cash Per Share
- TWD 9.13
- Tangible Book Value Per Share
- TWD 9.13
Margins
Gross margin is -1322.58%, with operating margin of -17694.31%, and net profit margin of -15720.88%.
- Gross Margin
- -1322.58%
- Operating Margin
- -17694.31%
- Pretax Margin
- -15720.88%
- Net Profit Margin
- -15720.88%
- EBITDA Margin
- -16298.94%
- EBIT Margin
- -17694.31%
Analyst Forecast
The average price target for CHO Pharma, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -46.88%
- EPS Growth Forecast
- -16.35%
